These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32232474)

  • 21. A timely update of global COVID-19 vaccine development.
    Klavinskis LS; Liu MA; Lu S
    Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
    Baay M; Neels P
    Biologicals; 2020 Sep; 67():69-74. PubMed ID: 32829985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?
    Schaefer GO; Tam CC; Savulescu J; Voo TC
    Vaccine; 2020 Jul; 38(33):5085-5088. PubMed ID: 32540271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 25. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
    Shih HI; Wu CJ; Tu YF; Chi CY
    Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [SARS coronavirus-2 vaccines: options and state-of-the-art].
    Huckriede ALW
    Ned Tijdschr Geneeskd; 2020 Sep; 164():. PubMed ID: 33030329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covid-19: Vaccine trials need more transparency to enable scrutiny and earn public trust, say experts.
    Mahase E
    BMJ; 2020 Oct; 371():m4042. PubMed ID: 33093065
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 32. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
    Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
    J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Zhu FC; Guan XH; Li YH; Huang JY; Jiang T; Hou LH; Li JX; Yang BF; Wang L; Wang WJ; Wu SP; Wang Z; Wu XH; Xu JJ; Zhang Z; Jia SY; Wang BS; Hu Y; Liu JJ; Zhang J; Qian XA; Li Q; Pan HX; Jiang HD; Deng P; Gou JB; Wang XW; Wang XH; Chen W
    Lancet; 2020 Aug; 396(10249):479-488. PubMed ID: 32702299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
    Graepel KW; Kochhar S; Clayton EW; Edwards KE
    J Infect Dis; 2020 Jun; 222(2):180-182. PubMed ID: 32365191
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 37. Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    Strassle C; Jardas E; Ochoa J; Berkman BE; Danis M; Rid A; Taylor HA
    N Engl J Med; 2020 Nov; 383(20):1897-1899. PubMed ID: 33085884
    [No Abstract]   [Full Text] [Related]  

  • 38. Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lane R
    Lancet; 2020 Apr; 395(10232):1247. PubMed ID: 32305089
    [No Abstract]   [Full Text] [Related]  

  • 39. In Pursuit of a SARS-CoV-2 Vaccine.
    Johnson AR; McDonald AR; Malay DS
    J Foot Ankle Surg; 2020; 59(6):1133-1134. PubMed ID: 33129444
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 vaccine trials in Africa.
    Makoni M
    Lancet Respir Med; 2020 Nov; 8(11):e79-e80. PubMed ID: 32896275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.